Available for Acquisition: Virulite, LLC and the Cold Sore Machine

Usually we can not disclose the identity of a client for a variety of reasons.  For our newest client, Virulite, LLC. not only can we disclose the identity, we even issued a press release via Business Wire that they are available for acquisition.  They do not have that many employees, they all know about a possible sale, and in this case there is benefit in spreading a wide net into pharmaceutical and medical device manufacturing companies.

Virulite, LLC. is the manufacturer of the Virulite device, an innovative hand-held device that uses near infra-red light to reduce the healing time of cold sores by up to 50%.   It was developed in the UK, went through clinical trials there, and is even approved and sold by the National Health Service. 

They have not yet developed a market outside the UK, which is why they retained our services.  I was hesitant at first because we don’t typically represent clients that demand a large purchase price without earnings to back it up (usually a venture capitalist is what a company like this needs), but in this case a few things changed my mind.

One compelling reason to take this project on was the simple fact that the device works.  I read the reports, but what really drove it home was when I did a Google search and found testimonials on the web for the time it was being sold on Walgreens online for their test marketing.  The testimonials were outstanding.  I was intrigued.

The market is nothing less than massive, with GlaxoSmithKline doing around $2 billion in cold sore remedies.  As you know, many of the drug companies like GSK have to continually bring new products to market as their old drugs dropped out of patent protection and become prey to generic knock offs.  Did you know it takes an average of $800 million of R&D to develop a new drug?  Further, the drug companies are seeking non-drug remedies for some ailments, because of the liability of using drugs. 

It all adds up to the potential for Virulite to find a good home with a company here in the US, most likely a pharmaceutical firm or medical device company.